Nasopharyngeal carcinoma Trials in Fuzhou, China
Conditions / Nasopharyngeal carcinoma / Fuzhou, China
Nasopharyngeal carcinoma has been the subject of sustained clinical investigation across multiple research sites.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05587374 | Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04974398 | A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05340491 | Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial | RECRUITING | PHASE3 |
| NCT02633176 | Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma | UNKNOWN | PHASE3 |
| NCT06307314 | Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis | RECRUITING | — |
| NCT07328854 | 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma | RECRUITING | PHASE3 |
| NCT06239727 | Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response | RECRUITING | PHASE3 |
| NCT05956587 | A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors | RECRUITING | PHASE2 |
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | UNKNOWN | PHASE3 |
| NCT02915432 | The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC | UNKNOWN | PHASE1/PHASE2 |